First-Line Inhaled Steroids for Pediatric Asthma Gain Support

2006 ◽  
Vol 36 (8) ◽  
pp. 62
Author(s):  
BRUCE JANCIN
1995 ◽  
Vol 2 (suppl a) ◽  
pp. 10A-12A
Author(s):  
André Cartier

Corticosteroids are the most potent inhaled anti-inflammatory drugs for asthma treatment. This paper reviews the clinical evidence supporting the early use of inhaled steroids in asthma as a first line treatment. Inhaled steroids can probably alter the course of asthma, especially in mild asthmatics. Once they have been shown to improve control of asthma and even if the need for beta2-agonists is virtually nil, their use should be continued at low doses (ie, equivalent to 400 to 500 μg of budesonide or beclomethasone) for at least one year before attempting to reduce the dosage.


1995 ◽  
Vol 2 (suppl a) ◽  
pp. 13A-18A
Author(s):  
Sheldon Spier

The benefits derived from the use or inhaled steroids in pediatric asthma are reviewed in relation to the age of the patient, the delivery system and the compliance versus frequency of administration of these medications. Side effects are discussed with regard to the age or the child and the following systems: the eyes, the skin, the oropharynx, the voice, the immune system, lipid and carbohydrate metabolism, adrenal glands, bone metabolism and growth.


2004 ◽  
Vol 171 (4S) ◽  
pp. 440-440
Author(s):  
Fernando J. Bianco ◽  
Mark B. Fisher ◽  
Michael L. Cher ◽  
Richard Everson ◽  
Wael A. Sakr ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 503-503
Author(s):  
Richard Vanlangendock ◽  
Ramakrishna Venkatesh ◽  
Jamil Rehman ◽  
Chandra P. Sundaram ◽  
Jaime Landman

2009 ◽  
Vol 40 (9) ◽  
pp. 32
Author(s):  
MITCHEL L. ZOLER
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document